{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T17:28:00Z","timestamp":1788974880487,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.nano.2021.102490","type":"journal-article","created":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T18:30:00Z","timestamp":1636137000000},"page":"102490","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Surfactant free synthesis of cationic nano-vesicles: A safe triple drug loaded vehicle for the topical treatment of cutaneous leishmaniasis"],"prefix":"10.1016","volume":"40","author":[{"given":"Sidra","family":"Khalid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad","family":"Salman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kashif","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiza ur","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iffat","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhay R.","family":"Satoskar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gul Majid","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Junaid","family":"Dar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.nano.2021.102490_bb0005","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1080\/10717544.2018.1494222","article-title":"Sodium stibogluconate loaded nano-deformable liposomes for topical treatment of leishmaniasis: macrophage as a target cell","volume":"25","author":"Dar","year":"2018","journal-title":"Drug Deliv"},{"key":"10.1016\/j.nano.2021.102490_bb0010","unstructured":"WHO. Control of the leishmaniases: report of a meeting of the WHO Expert Committee on the Control of Leishmaniases, Geneva, 22-26 March 2010. 2010."},{"key":"10.1016\/j.nano.2021.102490_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105256","article-title":"Nano-elastic liposomes as multidrug carrier of sodium stibogluconate and ketoconazole: a potential new approach for the topical treatment of cutaneous leishmaniasis","volume":"145","author":"Dar","year":"2020","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.nano.2021.102490_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2019.110421","article-title":"Antileishmanial and cytotoxic activities of ionic surfactants compared to those of miltefosine","volume":"183","author":"Alonso","year":"2019","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.nano.2021.102490_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118900","article-title":"Topical treatment of cutaneous leishmaniasis with novel amphotericin B-miltefosine co-incorporated second generation ultra-deformable liposomes","volume":"573","author":"Dar","year":"2020","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.nano.2021.102490_bb0030","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jconrel.2007.10.009","article-title":"Dual role of hexadecylphosphocholine (miltefosine) in thermosensitive liposomes: active ingredient and mediator of drug release","volume":"125","author":"Lindner","year":"2008","journal-title":"J Control Release"},{"issue":"7","key":"10.1016\/j.nano.2021.102490_bb0035","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/jphp.12548","article-title":"Topical formulations of miltefosine for cutaneous leishmaniasis in a BALB\/c mouse model","volume":"68","author":"Van Bocxlaer","year":"2016","journal-title":"J Pharm Pharmacol"},{"issue":"3","key":"10.1016\/j.nano.2021.102490_bb0040","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.tmaid.2006.09.004","article-title":"Cutaneous leishmaniasis treatment","volume":"5","author":"Minodier","year":"2007","journal-title":"Travel Med Infect Dis"},{"issue":"12","key":"10.1016\/j.nano.2021.102490_bb0045","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1001\/archderm.142.12.1575","article-title":"Imiquimod in combination with meglumine antimoniate for cutaneous leishmaniasis: a randomized assessor-blind controlled trial","volume":"142","author":"Firooz","year":"2006","journal-title":"Arch Dermatol"},{"issue":"12","key":"10.1016\/j.nano.2021.102490_bb0050","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1086\/518172","article-title":"Role of imiquimod and parenteral meglumine antimoniate in the initial treatment of cutaneous leishmaniasis","volume":"44","author":"Arevalo","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.nano.2021.102490_bb0055","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/17425247.2020.1700227","article-title":"Development and evaluation of novel miltefosine-polyphenol co-loaded second generation nano-transfersomes for the topical treatment of cutaneous leishmaniasis","volume":"17","author":"Dar","year":"2020","journal-title":"Expert Opin Drug Deliv"},{"issue":"37","key":"10.1016\/j.nano.2021.102490_bb0060","doi-asserted-by":"crossref","first-page":"12875","DOI":"10.1021\/bi980096y","article-title":"Liposome\u2013cell interactions in vitro: effect of liposome surface charge on the binding and endocytosis of conventional and sterically stabilized liposomes","volume":"37","author":"Miller","year":"1998","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.nano.2021.102490_bb0065","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1128\/AAC.00524-10","article-title":"Combination therapy with paromomycin-associated stearylamine-bearing liposomes cures experimental visceral leishmaniasis through Th1-biased immunomodulation","volume":"55","author":"Banerjee","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.nano.2021.102490_bb0070","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.exppara.2019.03.004","article-title":"The activity of encapsulated meglumine antimoniate in stearylamine-bearing liposomes against cutaneous leishmaniasis in BALB\/c mice","volume":"200","author":"Moosavian","year":"2019","journal-title":"Exp Parasitol"},{"issue":"3","key":"10.1016\/j.nano.2021.102490_bb0075","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0278-6915(02)00258-2","article-title":"Review of the oral toxicity of polyvinyl alcohol (PVA)","volume":"41","author":"DeMerlis","year":"2003","journal-title":"Food Chem Toxicol"},{"issue":"3","key":"10.1016\/j.nano.2021.102490_bb0080","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3109\/02652048.2016.1156175","article-title":"Surfactant-free poly (lactide-co-glycolide) nanoparticles for improving in vitro anticancer efficacy of tetrandrine","volume":"33","author":"Shi","year":"2016","journal-title":"J Microencapsul"},{"issue":"7","key":"10.1016\/j.nano.2021.102490_bb0085","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1080\/1061186X.2017.1298601","article-title":"Polymer-based drug delivery: the quest for local targeting of inflamed intestinal mucosa","volume":"25","author":"Dar","year":"2017","journal-title":"J Drug Target"},{"key":"10.1016\/j.nano.2021.102490_bb0090","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.powtec.2013.08.025","article-title":"Nanoparticles in wastewaters: hazards, fate and remediation","volume":"255","author":"Liu","year":"2014","journal-title":"Powder Technol"},{"issue":"2","key":"10.1016\/j.nano.2021.102490_bb0095","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","article-title":"Ethical guidelines for investigations of experimental pain in conscious animals","volume":"16","author":"Zimmermann","year":"1983","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.nano.2021.102490_bb0100","first-page":"601","article-title":"Studies on self-nanoemulsifying drug delivery system of flurbiprofen employing long, medium and short chain triglycerides","volume":"30","author":"Daar","year":"2017","journal-title":"Pak J Pharm Sci"},{"issue":"1","key":"10.1016\/j.nano.2021.102490_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-31693-y","article-title":"Liposomes can both enhance or reduce drugs penetration through the skin","volume":"8","author":"Peralta","year":"2018","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.nano.2021.102490_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-019-1396-x","article-title":"Design and toxicity evaluation of novel fatty acid-amino acid-based biocompatible surfactants","volume":"20","author":"Katiyar","year":"2019","journal-title":"AAPS PharmSciTech"},{"issue":"1\u20132","key":"10.1016\/j.nano.2021.102490_bb0115","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ijpharm.2009.07.038","article-title":"Study on the mechanisms of chitosan and its derivatives used as transdermal penetration enhancers","volume":"382","author":"He","year":"2009","journal-title":"Int J Pharm"},{"issue":"17","key":"10.1016\/j.nano.2021.102490_bb0120","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.3390\/molecules25174002","article-title":"Activity of amphotericin B-loaded chitosan nanoparticles against experimental cutaneous leishmaniasis","volume":"25","author":"Riezk","year":"2020","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.nano.2021.102490_bb0125","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3109\/10717544.2014.902146","article-title":"Novel carbopol-based transfersomal gel of 5-fluorouracil for skin cancer treatment: in vitro characterization and in vivo study","volume":"22","author":"Khan","year":"2015","journal-title":"Drug Deliv"},{"issue":"2","key":"10.1016\/j.nano.2021.102490_bb0130","first-page":"255","article-title":"Effect of zeta potential on the properties of nano-drug delivery systems-a review (part 1)","volume":"12","author":"Honary","year":"2013","journal-title":"Tropical Journal of Pharmaceutical Research"},{"issue":"1\u20132","key":"10.1016\/j.nano.2021.102490_bb0135","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ijpharm.2006.12.045","article-title":"Cytotoxicity of submicron emulsions and solid lipid nanoparticles for dermal application","volume":"337","author":"Weyenberg","year":"2007","journal-title":"Int J Pharm"},{"issue":"12","key":"10.1016\/j.nano.2021.102490_bb0140","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.3390\/molecules24122322","article-title":"Niosomal nanocarriers for enhanced skin delivery of quercetin with functions of anti-tyrosinase and antioxidant","volume":"24","author":"Lu","year":"2019","journal-title":"Molecules"},{"issue":"9","key":"10.1016\/j.nano.2021.102490_bb0145","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1517\/17425247.2012.701204","article-title":"Drug delivery systems for the topical treatment of cutaneous leishmaniasis","volume":"9","author":"Carneiro","year":"2012","journal-title":"Expert Opin Drug Deliv"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963421001337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963421001337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:18:08Z","timestamp":1761549488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963421001337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":29,"alternative-id":["S1549963421001337"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2021.102490","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surfactant free synthesis of cationic nano-vesicles: A safe triple drug loaded vehicle for the topical treatment of cutaneous leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2021.102490","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102490"}}